Is hepatocellular carcinoma viability important when using intraoperative blood salvage during liver transplantation?-Reference-Cited by-同舟云学术

Is hepatocellular carcinoma viability important when using intraoperative blood salvage during liver transplantation?

Published:2023-07-31 Issue:3 Volume:12 Page:145-151
ISSN:2636-0004
Container-title:International Journal of Gastrointestinal Intervention
language:en
Short-container-title:Int J Gastrointest Interv

Author:

Nasser Ahmed¹,Smith Victoria²,Campbell Niamh¹,Rivers-Bowerman Michael Devin³,Stueck Ashley Elispath⁴,Costa Andreu Francesc³⁵,Arseneau Riley⁴,Westhaver Lauren⁴,Gala-Lopez Boris Luis²⁵

Affiliation:

1. Faculty of Medicine, Dalhousie University, Halifax, NS, Canada

2. Department of Surgery, Dalhousie University, Halifax, NS, Canada

3. Department of Radiology, Dalhousie University, Halifax, NS, Canada

4. Department of Pathology, Dalhousie University, Halifax, NS, Canada

5. Department of Microbiology & Immunology and Pathology, Beatrice Hunter Cancer Research Institute, QEII Health Science Centre, Dalhousie University, Halifax, NS, Canada

Publisher

Society of Gastrointestinal Intervention

Subject

Gastroenterology,Radiology, Nuclear Medicine and imaging,Oncology,Hepatology

Link

http://pdf.medrang.co.kr/GI/2023/012/IJGII012-03-145.pdf

Reference39 articles.

1. Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma

2. Ozer Etik D, Suna N, Boyacioglu AS. Management of hepatocellular carcinoma: prevention, surveillance, diagnosis, and staging. Exp Clin Transplant. 2017;15(Suppl 2):31-5.

3. Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions

4. Liquid biopsy in the clinical management of hepatocellular carcinoma

5. Effect of HBV-HDV co-infection on HBV-HCC co-recurrence in patients undergoing living donor liver transplantation